ICTR in the News: Johns Hopkins inHealth Hosts Event About the Challenges Surrounding the Future of Immunotherapy and Precision Medicine
Posted by: Crystal Williams on: March 6, 2017 | Print This Page
Johns Hopkins inHealth, an initiative of Johns Hopkins aimed at moving the field of individualized health forward, will kick off a brand-new event series called On the Road to Precision Medicine Health Care Leader Series. The series will address some of the challenges and obstacles faced in the field of precision medicine. The inaugural event taking place
March 8 at the National Press Club will focus on the future of immunotherapy. Leading experts will gather to discuss topics such as cost, communication, research and health care delivery
“Immunotherapy: Precision Medicine in Action”
An expert panel will provide insight about the obstacles immunotherapy is facing today.
Wednesday, March 8, 2017
National Press Club
529 14th St. NW
13th Floor, Fourth Estate Room
Washington, DC 20045
Executive Director, FasterCures
Roy Baynes, M.D., Ph.D.
Senior Vice President, Clinical Development and Chief Medical Officer, Merck Research Laboratories
Glenn Dranoff, M.D.
Global Head of Exploratory Immuno-Oncology, Novartis
Elizabeth Jaffee, M.D.
Associate Director, Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy
Deputy Director, Johns Hopkins Kimmel Cancer Center
William Nelson, M.D., Ph.D.
Director, Johns Hopkins Kimmel Cancer Center
FOR THE MEDIA